Benralizumab Suppliers & Bulk Manufacturers
Available Forms: Injection
Available Strengths: 30 mg/mL
Reference Brands: Fasenra (USA/EU)
Category: Respiratory Disorder
Benralizumab is a monoclonal antibody used for the treatment of severe eosinophilic asthma. It works by targeting and binding to the interleukin-5 receptor alpha (IL-5Rα) on eosinophils, leading to their rapid depletion. This helps reduce inflammation in the airways and improves breathing. Benralizumab is administered via subcutaneous injection once every four to eight weeks. Benralizumab is available in Injection and strengths such as 30 mg/mL. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Benralizumab is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.
| Technical Specifications & Supply Details | |
|---|---|
| Lead Time | 7 to 60 days (depending on batch size & schedule) |
| MOQ | As per manufacturer’s batch size |
| COA | Available with every batch |
| Regulatory Dossier / DMF | Available upon request |
| Export Documentation | FSC, COA, Manufacturing License, Product Permission |
| Standards | IP, BP, USP |
| Certifications | WHO-GMP, EU-GMP, USFDA (as applicable) |
Benralizumab can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Benralizumab is used to treat severe eosinophilic asthma in adults and adolescents, helping to reduce asthma attacks and improve breathing.
Benralizumab is made from a humanized monoclonal antibody that targets the interleukin-5 receptor (IL-5Rα) on eosinophils, leading to their depletion and reducing inflammation in the airways.
The trade name of Benralizumab is Fasenra.
Benralizumab is made by AstraZeneca.
The generic name of the product is Benralizumab.
The brand name of Benralizumab is Fasenra.
Benralizumab is manufactured by AstraZeneca in the United States and the United Kingdom.
Related Products
Levalbuterol
Strength:
0.31 mg, 0.63 mg, 1.25 mg
Form: Inhalation solution
Reference Brands: Xopenex (USA/EU)
View Details
Umeclidinium Bromide
Strength:
62.5 mcg
Form: dry-powder inhaler
Reference Brands: Incruse Ellipta (USA)
View Details
Mannitol
Strength:
40mg
Form: inhalation powder capsules
Reference Brands: Bronchitol (USA/EU)
View DetailsQuick Response Guaranteed | Verified Suppliers
